BDBM50178192 CHEMBL3814772::US10206931, Example 123
SMILES: C[C@@H](Oc1ccc2NC(=O)C[C@@H](C)Nc2c1)c1ccccc1
InChI Key: InChIKey=ORPRVEZBBPKRRY-CHWSQXEVSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM50178192 (CHEMBL3814772 | US10206931, Example 123) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | PubMed | n/a | n/a | 8.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Constellation Pharmaceuticals Curated by ChEMBL | Assay Description Displacement of biotinylated ligand from recombinant His-tagged BRD4 bromodomain-1 (unknown origin) incubated for 10 mins by TR-FRET assay | ACS Med Chem Lett 7: 531-6 (2016) BindingDB Entry DOI: 10.7270/Q20G3N3S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
BRD4 BD1 (aa 42-168) (Homo sapiens (Human)) | BDBM50178192 (CHEMBL3814772 | US10206931, Example 123) | PDB GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | US Patent | n/a | n/a | 1.29E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD4 BD142-168 was cloned, expressed, and purified to. BRD4 binding and inhibition was assessed by monitoring the engagement ... | US Patent US10206931 (2019) BindingDB Entry DOI: 10.7270/Q2GM89FR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CREB-binding protein (Homo sapiens (Human)) | BDBM50178192 (CHEMBL3814772 | US10206931, Example 123) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | PDB US Patent | n/a | n/a | 652 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ... | US Patent US10206931 (2019) BindingDB Entry DOI: 10.7270/Q2GM89FR | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
CREB-binding protein (Homo sapiens (Human)) | BDBM50178192 (CHEMBL3814772 | US10206931, Example 123) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | PDB PubMed | n/a | n/a | 4.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Constellation Pharmaceuticals Curated by ChEMBL | Assay Description Displacement of biotinylated ligand from recombinant His-tagged CBP (unknown origin) incubated for 10 mins by TR-FRET assay | ACS Med Chem Lett 7: 531-6 (2016) BindingDB Entry DOI: 10.7270/Q20G3N3S | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) |